{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:48Z","timestamp":1786984188896,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajem.2023.01.050","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:15:45Z","timestamp":1675250145000},"page":"124-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review"],"prefix":"10.1016","volume":"66","author":[{"given":"Mridul","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Matthew","family":"Belford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David X.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraschandra","family":"Vallabhajosyula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8 Pt A","key":"10.1016\/j.ajem.2023.01.050_bb0005","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1053\/j.jvca.2022.01.002","article-title":"Angiotensin II in patients with shock on mechanical circulatory support: a single-center retrospective case series","volume":"36","author":"Mohamed","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"10.1016\/j.ajem.2023.01.050_bb0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13054-018-2225-4","article-title":"Angiotensin in ECMO patients with refractory shock","volume":"22","author":"Ostermann","year":"2018","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.ajem.2023.01.050_bb0015","article-title":"Catecholamine-sparing effect of angiotensin II in an Anephric patient with mixed shock after cardiac revascularization surgery: a case report","volume":"14","author":"Cutler","year":"2020","journal-title":"A A Pract"},{"issue":"9","key":"10.1016\/j.ajem.2023.01.050_bb0020","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1053\/j.jvca.2020.07.087","article-title":"Angiotensin II for critically ill patients with shock after heart transplant","volume":"35","author":"Cutler","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"10.1016\/j.ajem.2023.01.050_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II is associated with rapid blood pressure response and vasopressor sparing in patients with Vasoplegia after cardiac surgery: a post-hoc analysis of angiotensin II for the treatment of high-output shock (ATHOS-3) study","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"10.1016\/j.ajem.2023.01.050_bb0030","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1213\/ANE.0000000000005953","article-title":"The association between angiotensin II and renin kinetics in patients after cardiac surgery","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.ajem.2023.01.050_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/10600280221099928","article-title":"Evaluation of the addition of angiotensin II in patients with shock after cardiac surgery at a veterans affairs medical center","volume":"57","author":"Bird","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.ajem.2023.01.050_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.14797\/mdcvj.576","article-title":"Angiotensin II: a multimodal approach to Vasoplegia in a cardiac setting","volume":"17","author":"Sovic","year":"2021","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"11","key":"10.1016\/j.ajem.2023.01.050_bb0045","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1053\/j.jvca.2019.03.004","article-title":"Synthetic human angiotensin II for Postcardiopulmonary bypass Vasoplegic shock","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"10.1016\/j.ajem.2023.01.050_bb0050","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.athoracsur.2018.11.047","article-title":"Use of angiotensin II for post cardiopulmonary bypass Vasoplegic syndrome","volume":"108","author":"Evans","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.ajem.2023.01.050_bb0055","article-title":"Protocol compliance guiding angiotensin II use in post cardiovascular surgery Vasoplegia","volume":"4","author":"Ten Lohuis","year":"2022","journal-title":"Crit Care Explor"},{"issue":"3","key":"10.1016\/j.ajem.2023.01.050_bb0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/aca.aca_98_21","article-title":"Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: a case series","volume":"25","author":"Konkol","year":"2022","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.ajem.2023.01.050_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.xjtc.2020.08.007","article-title":"Successful use of angiotensin II for vasoplegia after thoracoabdominal aortic aneurysm repair","volume":"4","author":"Chatterjee","year":"2020","journal-title":"JTCVS Tech"},{"issue":"10","key":"10.1016\/j.ajem.2023.01.050_bb0070","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1097\/CCM.0000000000004502","article-title":"Use of angiotensin II in severe Vasoplegia after left pneumonectomy requiring cardiopulmonary bypass: a renin response analysis","volume":"48","author":"Trethowan","year":"2020","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.ajem.2023.01.050_bb0075","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1053\/j.jvca.2019.03.054","article-title":"Use of angiotensin II for Vasoplegic shock in a combined heart and liver transplant recipient with systolic anterior motion physiology","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T21:10:53Z","timestamp":1760562653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675723000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":15,"alternative-id":["S0735675723000542"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2023.01.050","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2023.01.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}